FF-10502-01

· Fujifilm Pharmaceuticals U.S.A., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FF-10502-01, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]